Call for Papers - September 2021 Issue | Submission deadline: September 20, 2021 | Processing fee for publication: NIL

Molecular docking and molecular dynamic simulation of phytochemical derived compounds as potential anti cancer agent against tyrosine kinase

Siddharth Bhatt
Pioneer Pharmacy Degree College, Nr. Ajwa Crossing, Sayajipura, Vadodara, Gujarat, India-391740
Dhara Patel
Pioneer Pharmacy Degree College, Nr. Ajwa Crossing, Sayajipura, Vadodara, Gujarat, India-391740.
Sharav Desai
Pioneer Pharmacy Degree College, Nr. Ajwa Crossing, Sayajipura, Vadodara, Gujarat, India-391740.
Dhananjay Meshram
Pioneer Pharmacy Degree College, Nr. Ajwa Crossing, Sayajipura, Vadodara, Gujarat, India-391740.

Dimensions

Plum Analytics

Abstract

There is a continuous requirement to develop novel, safe, effective and affordable anti-cancer drugs because Cancer is a serious disease at current situation. A huge number of patients die annually due to cancer disease.  Phytochemical are the secondary metabolites of medicinal plants and significantly used in conventional cancer research.  Bioactive phytochemical is favored as they claim differentially on cancer cell only without altering normal cell. Carcinogenesis is an intricate process and includes multifold signaling procedures. Phytochemical are pleiotropic in nature, function and target these events in multiple manners so they are considered as most appropriate candidate for drug development. The aim of the present research was to find out the anti-cancer activity of the phytochemical constituents through computer aided drug design approach. In this experiment, we have find total 42 natural compounds with anti-cancer activity against the cancer target 1QCF tyrosine kinase. The data set comprising of phytochemical compounds was used for virtual screening and molecular docking in PyRx software. Along with screened compound, hit compound Carnosic acid was further docked to confirm the binding mode and confirmed the effective inhibition of 1QCF and anticancer activity. Molecular dynamic simulation studies were done to confirm the stability of the protein and ligand complex during a simulation. Parameters like RMSD, RMSF, and radius of gyration were experiential to understand the fluctuations. Protein-ligand interaction studies also expose that enough hydrogen and hydrophobic bonds are present to validate our results. Our study suggests that the potential use of Carnosic acid can come out as a potential candidate and in turn prevent cancer.

Keywords

  • Phytochemicals,
  • Anticancer,
  • Tyrosine Kinase,
  • Virtual Screening,
  • Molecular Docking,
  • Molecular Dynamic Simulation
  • ...More
    Less

References

  1. D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation, cell, 144 (2011) 646–674.
  2. D. Hanahan, R.A. Weinberg, The hallmarks of cancer, cell, 100 (2000) 57–70.
  3. World Health Organization, Fact sheet, (2015) http://www.who.int/mediacentre/factsheets/fs297/en/ (2015).
  4. Cancer, I. A. f. R. o. World cancer report 2014. Geneva: WHO (2014).
  5. M.J. Thun, J.O. DeLancey, M.M,Center A. Jemal, E.M. Ward, The global burden of cancer: priorities for prevention, Carcinogenesis, 31 (2010) 100–110.
  6. E. Safarzadeh, S. Sandoghchian Shotorbani, B. Baradaran, Herbal medicine as inducers of apoptosis in cancer treatment, Advanced pharmaceutical bulletin, 4 (2014) 421–427.
  7. F. Qi, A. Li, Y. Inagaki, J. Gao, J. Li, N. Kokudo, Xiao-Kang Li, W. Tang, Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer, BioScience Trends, 4 (2010) 297–307.
  8. D.S. Fabricant, N.R. Farnsworth, The value of plants used in traditional medicine for drug discovery, Environmental Health Perspectives, 109 (2001) 69–75.
  9. G. Tan, C. Gyllenhaal, D.D. Soejarto, Biodiversity as a source of anticancer drugs, Current Drug Targets, 7 (2006) 265–277.
  10. A. Saklani, S.K. Kutty, Plant-derived compounds in clinical trials, Drug Discovery Today, 13 (2008)161–171.
  11. S. Zhang, Computer-aided drug discovery and development, Methods in Molecular Biology, 716 (2011) 23-38.
  12. X.Y. Meng, H.X. Zhang, M. Mezei, M. Cui, Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery, Current Computer-Aided Drug Design, 7 (2011) 146-157.
  13. A. Lavecchia, C. Di Giovanni, Virtual screening strategies in drug discovery: a critical review, Current Medicinal Chemistry, 20 (2013) 2839-2860.
  14. A.S. Reddy, S.P. Pati, P.P. Kumar, H.N. Pradeep, G.N, Sastry, Virtual screening in drug discovery - a computational perspective, Current Protein & Peptide Science, 8 (2007) 329-351.
  15. W.L. Jorgensen, The many roles of computation in drug discovery, Science, 303 (2004) 1813-1818.
  16. M.A. Lemmon, J. Schlessinger Cell signaling by receptor tyrosine kinases, Cell, 141 (2010) 1117–1134.
  17. E. Li, K. Hristova Role of receptor tyrosine kinase trans membrane domains in cell signaling and human pathologies, Biochemistry, 45 (2006) 6241–6251.
  18. A. Daina, Michielin O, Zoete V, Swiss, ADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Scientific Reports, 7 (2017) 42717.
  19. T. Sander, J. Freyss, Mv. Korff, J.R. Reich, C. Rufener. OSIRIS, an entirely in-house developed drug discovery informatics system, Journal of Chemical Information and Modeling, 49 (2009) 232-246.
  20. T. Sander, J. Freyss, M. von Korff, C. Rufener, DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis, Journal of Chemical Information and Modeling, 55 (2015) 460-73.
  21. S.R. Hubbard, W.T. Miller, Receptor tyrosine kinases: Mechanisms of activation and signaling, Current Opinion in Cell Biology, 19 (2007) 117–123.
  22. J. Schlessinger, Cell signaling by receptor tyrosine kinases, Cell, 103 (2003) 211–225.
  23. M.A. Isa, R.S. Majumdar, S. Haider, In silico identification of potential inhibitors against shikimate dehydrogenase through virtual screening and toxicity studies for the treatment of tuberculosis, International Microbiology, 22 (2019) 7-17.
  24. M.U. Johansson, V. Zoete, O. Michielin, N. Guex, Defining and searching for structural motifs using DeepView/Swiss-PdbViewer, BMC Bioinformatics, 13 (2012) 173.
  25. A. Porollo, J. Meller, POLYVIEW-MM: web-based platform for animation and analysis of molecular simulations, Nucleic Acids Research, 38 (2010) W662-W666.
  26. S. Ramachandran, P. Kota F. Ding, N.V. Dokholyan, Automated minimization of stearic clashes in protein structures, Proteins, 79 (2011) 261-270.
  27. S. Luo, G.B. Lenon, H. Gill, A. Hung, D.A. Dias, M. Li, L. T. Nguyen, Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches, PLOS ONE, 15 (2020) e0231815.
  28. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, Journal of Computational Chemistry, 19 (1998) 1639-1662.
  29. J.C. Phillips, D.J. Hardy, J.D.C. Maia, J.E. Stone, J.V. Ribeiro, R.C. Bernardi, R. Buch, G. Fiorin, J. Hénin, W. Jiang, R. McGreevy, M. C. R. Melo, B. K. Radak, R. D. Skeel, A. Singharoy, Y. Wang, B. Roux, A. Aksimentiev, Z. Luthey-Schulten, L. V. Kalé1, K. Schulten, C. Chipot, E. Tajkhorshid, Scalable molecular dynamics on CPU and GPU architectures with NAMD, The Journal of Chemical Physics, 153 (2020) 044130.
  30. A. Bornot, C. Etchebest, A.G. de Brevern, Predicting protein flexibility through the prediction of local structures, Proteins, 79 (2011) 839-852.
  31. I. Kufareva, R. Abagyan, Methods of protein structure comparison, Methods in Molecular Biology, 857 (2012) 231-257.
  32. M. Lobanov, N.S. Bogatyreva, O.V. Galzitskaia, Radius of gyration is indicator of compactness of protein structure, Molecular Biology, 42 (2008) 701-706.
  33. I. Soteras Gutiérrez, F-Y. Lin, K. Vanommeslaeghe, J.A. Lemkul, K.A. Armacost, C.L. Brooks, A. D. MacKerell Jr, Parametrization of halogen bonds in the CHARMM general force field: Improved treatment of ligand-protein interactions, Bioorganic and Medicinal Chemistry, 24 (2016) 4812-4825.
  34. J.C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R. D. Skeel, L. Kalé, K. Schulten, Scalable molecular dynamics with NAMD, Journal of computational chemistry, 26 (2005) 1781-802.
  35. J.V. Ribeiro, R.C. Bernardi, T. Rudack, J.E. Stone, J.C. Phillips, P.L. Freddolino, QwikMD —Integrative Molecular Dynamics Toolkit for Novices and Experts, Scientific Reports, 6 (2016) 26536.
  36. J. Hsin, A. Arkhipov, Y. Yin, J.E. Stone, K. Schulten, Using VMD: an introductory tutorial, Current Protocol in Bioinformatics, 5 (57) (2008).
  37. S. Cosconati, S. Forli, A.L. Perryman, R. Harris, D.S. Goodsell, A.J. Olson, Virtual Screening with AutoDock: Theory and Practice, Expert Opinion on Drug Discovery, 5 (2010) 597-607.
  38. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A. J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, Journal of computational chemistry, 30 (2009) 2785-2791.

Downloads

PDF

Article Details

Volume 3, Issue 5, Year 2021

Published 2021-08-07

Downloads

Download data is not yet available.

How to Cite

Bhatt, S., Patel, D., Desai, S., & Meshram, D. (2021). Molecular docking and molecular dynamic simulation of phytochemical derived compounds as potential anti cancer agent against tyrosine kinase. International Research Journal of Multidisciplinary Technovation, 3(5), 11–25. https://doi.org/10.34256/irjmt2152

Plum Analytics